Xarelto patent expiry in india?

Rivaroxaban (brand name Xarelto) has multiple patent filings/processes/variations, so “the” expiry date in India depends on which specific patent you mean.

That said, the commonly cited situation for rivaroxaban/Xarelto in India is that compound (active ingredient) patent protection from Janssen/Roche has been broadly around 2026–2027, with additional exclusivity from later patents/registrations possibly extending market exclusivity in some form beyond the earliest “base” expiry. Final, exact dates require checking the India Patent Office register for the specific patent numbers covering:

• the drug substance (compound)
• formulations (e.g., specific tablet forms/dosage strengths)
• process patents
• any patent term extensions / data exclusivity relevant to the product’s approvals

If you want, I can pin it down precisely

Please tell me either:

1. the dosage strength you mean (e.g., 10 mg, 15 mg, 20 mg), and/or
2. whether you mean compound patent expiry or market exclusivity, and ideally
3. any patent number you’ve seen (if you have it)

…and I’ll help you interpret the likely expiry/next generic entry timing in India based on the specific rights.